Cargando…

Comorbid Diabetes and COPD: Impact of corticosteroid use on diabetes complications

OBJECTIVE: To identify if there is a dose-dependent risk of diabetes complications in patients treated with corticosteroids who have both diabetes and chronic obstructive pulmonary disorder (COPD). RESEARCH DESIGN AND METHODS: A retrospective study of administrative claims data from the Australian G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caughey, Gillian E., Preiss, Adrian K., Vitry, Agnes I., Gilbert, Andrew L., Roughead, Elizabeth E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781532/ https://www.ncbi.nlm.nih.gov/pubmed/23735725 http://dx.doi.org/10.2337/dc12-2197

Ejemplares similares

Prevalence of comorbidity of chronic diseases in Australia
por: Caughey, Gillian E, et al.
Publicado: (2008)

Influence of Comorbidities on Therapeutic Progression of Diabetes Treatment in Australian Veterans: A Cohort Study
por: Vitry, Agnes I., et al.
Publicado: (2010)

Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States
por: Othman, Noordin, et al.
Publicado: (2010)

Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review
por: Othman, Noordin, et al.
Publicado: (2009)

Multimorbidity research challenges: where to go from here?
por: Caughey, Gillian E., et al.
Publicado: (2011)

Evaluating medication-related quality of care in residential aged care: a systematic review
por: Hillen, Jodie B, et al.
Publicado: (2015)

Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity
por: Caughey, Gillian E, et al.
Publicado: (2017)

Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study
por: Othman, Noordin, et al.
Publicado: (2010)

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study
por: Vitry, Agnes, et al.
Publicado: (2015)

Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data
por: Sluggett, Janet K, et al.
Publicado: (2013)

Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
por: Othman, Noordin, et al.
Publicado: (2010)

Inclusion of Older People Reflective of Real‐World Clinical Practice in Cardiovascular Drug Trials
por: Caughey, Gillian E., et al.
Publicado: (2020)

Variations in colorectal cancer pattern of care by age and comorbidity in South Australia
por: Gheybi, Kazzem, et al.
Publicado: (2023)

Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer
por: Gheybi, Kazzem, et al.
Publicado: (2023)

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
por: Ställberg, Björn, et al.
Publicado: (2020)

Sequence symmetry analysis graphic adjustment for prescribing trends
por: Preiss, Adrian Kym, et al.
Publicado: (2019)

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
por: Price, David B., et al.
Publicado: (2019)

Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions
por: Li, Ray J., et al.
Publicado: (2021)

Comorbidities of COPD
por: Cavaillès, Arnaud, et al.
Publicado: (2013)

Tailoring of corticosteroids in COPD management
por: De Coster, Daan A., et al.
Publicado: (2014)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Survival in COPD: Impact of Lung Dysfunction and Comorbidities
por: Miniati, Massimo, et al.
Publicado: (2014)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Managing comorbidities in COPD
por: Hillas, Georgios, et al.
Publicado: (2015)

Screening for comorbidities in COPD
por: Natali, Delphine, et al.
Publicado: (2020)

Guideline Compliance in Chronic Heart Failure Patients with Multiple Comorbid Diseases: Evaluation of an Individualised Multidisciplinary Model of Care
por: Ho, Tam H., et al.
Publicado: (2014)

Type 2 diabetes complications and comorbidity in Sub-Saharan Africans
por: Ekoru, Kenneth, et al.
Publicado: (2019)

Utilization and cost of drugs for diabetes and its comorbidities and complications in Kuwait
por: Alowayesh, Maryam S., et al.
Publicado: (2022)

Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications
por: Prada-Medina, Cesar A., et al.
Publicado: (2017)

Epidemiology and clinical impact of major comorbidities in patients with COPD
por: Smith, Miranda Caroline, et al.
Publicado: (2014)

Corticosteroids for Diabetic Macular Edema
por: Chawan-Saad, Jorge, et al.
Publicado: (2019)

Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry
por: Mao, Xihua, et al.
Publicado: (2021)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
por: Sahay, Rakesh Kumar, et al.
Publicado: (2020)

Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
por: Ng, Huah Shin, et al.
Publicado: (2018)

Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
por: Lacedonia, Donato, et al.
Publicado: (2021)

The effects of corticosteroids on COPD lung macrophages: a pooled analysis
por: Higham, Andrew, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ftd32dsmfkae8gecik746rgfpp